No Picture
Trading Ideas

GILD: Second Covid-19 Study of Remdesivir in China Suspended; Expect Key Data in Coming Weeks

Gilead’s (GILD) remdesivir study in China for mild-moderate Covid-19 patients has just been suspended due to poor enrollment. The news comes as the pandemic continues to wane in China, and follows the recently announced termination of the study for severe Covid-19 patients for similar reasons.According to reports, the mild-moderate study had planned to enroll 308 patients from Wuhan- but it remains unclear exactly how many enrolled to date. The stock is currently down 3% in today’s trading, but is still up 16% year-to-date.For RBC Capital analyst Brian Abrahams this latest update is a worrying sign of the drug’s efficacy. He …read more […]

No Picture
Trading Ideas

Berkshire Hathaway to take Occidental shares instead of cash dividends

Warren Buffett’s Berkshire Hathaway Inc agreed to take Occidental Petroleum Corp common shares in lieu of a first quarter cash dividend, helping relieve the strain on the trouble oil giant’s balance sheet. The sale would bring in less than $250 million at Occidental’s current price. Occidental’s market value is about $12.24 billion, a fraction of what it paid for Anadarko. …read more […]